ReviewCurrent medical imaging2026
Research Progress of MRI-based Radiomics in Rectal Cancer
Review in Current medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rectal cancer (RC), one of the most common malignant tumors, has a high incidence rate and mortality rate worldwide. Radiomics turns medical images into high-dimensional mineable data through high-throughput extraction algorithms, where the methods include filter-based algorithms and texture analysis. All these features are then combined with machine learning or deep learning algorithms to provide objective evidence to facilitate accurate diagnosis, radiation staging, radiotherapy planning, or prognosis prediction. Multi-parametric magnetic resonance imaging has been considered as one of the best modalities for performing radiomics analysis on rectal cancer because it can capture most features about tumor heterogeneity and micro-environment information. In the past few years, magnetic resonance imaging (MRI)-based radiomics has shown great promise in a variety of fields, including tumor-node-metastasis staging, monitoring pathological high-risk factors, predicting genetic markers, neoadjuvant therapy response evaluation, and prognostic survival analysis in rectal cancer. In this paper, we provide an overview of the current state-of-the-art on MRI radiomics for rectal cancer and present a comparison between the available methods of feature extraction, and provide a critical discussion of current issues and possible developments that might be pursued in future research on this topic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.